Zobrazeno 1 - 10
of 31
pro vyhledávání: '"E. V. Sanarova"'
Autor:
L. L. Nikolaeva, E. V. Sanarova, A. P. Kolpaksidi, S. D. Shcheglov, A. A. Rudakova, M. A. Baryshnikova, A. V. Lantsova
Publikováno v:
Biomedical Photonics, Vol 13, Iss 2, Pp 19-25 (2024)
The creation of combined nanomedicines and their controlled release under the influence of photoinduction is an actively developing branch of scientific research. This work is devoted to the development of models of solid lipid nanoparticles for a we
Externí odkaz:
https://doaj.org/article/11c3541c112146c989a7da986d6010b1
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 13, Iss 2, Pp 77-83 (2024)
Introduction. Improving the efficacy of chemotherapy is a non-trivial task of modern oncology. Its successful solution requires knowledge in many fields, including physiology, pathology, clinical oncology, pharmacology and others. The search for smal
Externí odkaz:
https://doaj.org/article/82f0498b2a064c9fb1b1135583594d0a
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 13, Iss 1, Pp 26-33 (2024)
Introduction. The search for new methods of therapy for non-small cell lung cancer (NSCLC) is an urgent task of modern science. Gefitinib is a targeted drug widely used in the treatment of NSCLC in patients with a mutation in the epidermal growth fac
Externí odkaz:
https://doaj.org/article/835e42ce8414401a85691e1b299c2abc
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 12, Iss 1, Pp 115-122 (2023)
Introduction. The Laboratory of Drug Formulation Development at the N. N. National Medical Research Center of Oncology developed a liposomal dosage form of FS tetra-3-phenylthio-pthalocyanine hydroxyluminide (TPHA) for which a simple, accurate and ea
Externí odkaz:
https://doaj.org/article/4056191b8c3a4cf58f37749e4277a3d7
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 11, Iss 3, Pp 97-112 (2022)
Introduction. Due to the discovery of antibodies (Ab) targeting molecule with high specificity to the ligand, the "magic bullet" concept has been successfully implemented with various immunoconjugated drugs. Since 1980, Ab conjugates with liposomes,
Externí odkaz:
https://doaj.org/article/b09fffbaf58541528c5816ef912b8f8a
Autor:
I. D. Gulyakin, L. L. Nikolaeva, N. A. Oborotova, M. V. Dmitrieva, A. V. Lantsova, E. V. Sanarova, O. L. Orlova, A. P. Polozkova, H. I. Lavrukhin, N. D. Bunyatyan
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 0, Iss 2, Pp 52-59 (2019)
There are several methods for solving the problem of an adequate dosage form for the hydrophobic and poorly soluble pharmaceutical substances which comprise a structure modification, preparation of solid dispersion systems, a change in pH, the use of
Externí odkaz:
https://doaj.org/article/f62bee0a608c4073866dcc9221c24606
Publikováno v:
Pharmaceutical Chemistry Journal. 56:974-978
Autor:
N. A. Oborotova, O. L. Orlova, M. A. Ogay, V. A. Evteev, M. V. Dmitrieva, A. V. Lantsova, G. A. Meerovich, L. M. Borisova, Yu. V. Olefir, A. B. Prokof’ev, N. D. Bunyatyan, M. M. Sapovskii, E. V. Sanarova, L. L. Nikolaeva, Z. J. Khadzhieva, M. P. Kiseleva, A. P. Polozkova
Publikováno v:
Bulletin of Experimental Biology and Medicine. 168:361-365
We studied specific antitumor activity of a liposomal drug based on tetra-3-phenylthiophthalocyanine aluminum hydroxide (lipophthalocyan) intended for photodynamic therapy. The optimal dose and protocol for photodynamic therapy with lipophthalocyan w
Autor:
Yu. V. Olefir, L. L. Nikolaeva, M. A. Ogai, A. V. Lantsova, E. V. Sanarova, N. A. Oborotova, D. V. Kompantsev, M. V. Dmitrieva, A. B. Prokof’ev, O. L. Orlova, Z. D. Khadzhieva, N. D. Bunyatyan, A. M. Shevchenko, A. P. Polozkova
Publikováno v:
Pharmaceutical Chemistry Journal. 53:986-990
An assay method for the excipients (sucrose, phosphatidylcholine, and cholesterol) of liposomal medicinal formulations of the phthalocyanine photosensitizer lipophthalocyan by TLC with chromatodensitometry was validated. Coefficients of standard resi
Autor:
E. A. Lesovaya, K. I. Kirsanov, A. V. Lantsova, A. A. Rudakova, E. V. Sanarova, N. V. Golubtsova, N. A. Oborotova, L. L. Nikolaeva, Z. A. Sokolova, L. R. Tilova, O. L. Orlova
Publikováno v:
Russian Journal of Biotherapy. 17:83-94
The use of liposomes as drug delivery systems today is a recognized approach to improving the effectiveness of treatment. Compared with other nanosized carriers, liposomes are highly biocompatible. However, in the literature, there are a number of da